Why we need the General
Practice Data for Planning and
Research (GPDPR) Programme
Professor Azeem Majeed
Head of Department of Primary Care & Public Health, Imperial College London
Twitter @Azeem_Majeed
Declarations
I have received funding for research using data from NHS medical records
from the NIHR, NHS, MRC and Wellcome Trust
I have been using NHS data for research and planning for over 25 years
I have written reports on the secondary uses of primary care data for the
Department of Health in 2002 and the Association of Public Health
Observatories in 2005
I worked as a Medical Adviser at the UK Office for National Statistics
during the period 1997-2004
I continue to work in NHS General Practice and in NHS Public Health in
addition to my academic role
England’s NHS faces major challenges
• Population of the UK is ageing
• Greater support is needed for frail, older patients
• Prevalence of many long term conditions – such as type 2
diabetes – is increasing
• Greater focus in prevention and healthy living needed
• Quality of care can vary between different general practices and
geographical areas
• Considerable financial pressures on government spending
• Since early 2020, we have been in the midst of the global
Covid-19 pandemic
• Good data on the health and healthcare use of the population of
England is essential for NHS planning, public health
surveillance and research
Expected rise in LTCs in England 2010-2040
Primary medical care data
Over the last 30 years, we have seen a shift away from recording medical
data on paper records in general practice
Data now recorded using electronic medical records in all NHS general
practices
Collected through day to day clinical work of family practitioners, primary
care physicians, nurses and other professionals
Additional data sent electronically to practices (e.g. lab results) or added
to medical records by primary care staff (hospital activity data)
Provides a unique resource for NHS planning, public health surveillance
and research
Value of NHS data was shown in the Covid-19 pandemic
Page 6
Strengths of primary care data
Population based
Most contacts with health services take place in primary care
Information on most aspects of care (morbidity, physical measurements,
investigations, treatment, prescribing, and outcomes & utilisation)
Page 7
Weaknesses of primary care data
Data has often come from volunteer practices & hence may not be
representative (e.g. Clinical Practice Research Datalink)
Quality & completeness of data recording varies widely
Lack of socio-economic & ethnic data
Multiple clinical systems, not currently well-linked to hospital systems
Data has been difficult & expensive to access in the past
GPDPR can help address some of these weaknesses
Information contained in GP medical records
Demographic data: e.g. date of birth, ethnicity
Clinical diagnoses: e.g. diabetes, pneumonia
Coded using Read codes / SNOMED in the UK
Measurement data: Blood pressure, height, weight, BMI
Preventive care: screening, smoking status, immunisations, health checks
Prescribing data: for drugs issued by GPs
Laboratory data: e.g. lipids, glucose, renal function for tests organised by
GPs
Covid-19 testing and vaccination data
Page 8
Page 9
Value of data can be improved through linkage
Hospital Episode Statistics
Office for National Statistics Mortality Records
Cancer Registration Data
National Audits (e.g. Diabetes)
Laboratory Data (e.g. tests organised by hospital specialists)
Imaging Data (e.g. x-rays, scans)
Page 10
Why is primary care data needed?
Help clinicians provide medical care
Plan health services
Measure clinical performance
Measure health service utilisation
Public health surveillance
Monitor inequalities
Health services research, clinical epidemiology, & clinical trials
Distribution of cardiovascular risk in England
Emergency hospital admissions in people with Type 2
Diabetes
Concerns about GPDPR
The programme was not well-publicised
Opt-out was made difficult (paper-based, not electronic)
Public concerns about how the data may be used and over confidentiality
If people opt out of the programme, that could reduce the validity of the
any analysis using the data
Many GPs are receiving opt out requests from patients
GPs have also been informed they need to perform a data protection
impact assessment (DPIA)
Final thoughts
GPDPR is essential for the NHS in England
Also essential for public health bodies, universities
Important to consider how the data could also support the UK life sciences
industry with suitable protections
Essential there is public trust in the programme and in data confidentiality
Needs to be overseen by an independent committee to build public
confidence and trust
Without good population-based data, the NHS “will be flying blind”

Gpdpr seminar june 2021

  • 1.
    Why we needthe General Practice Data for Planning and Research (GPDPR) Programme Professor Azeem Majeed Head of Department of Primary Care & Public Health, Imperial College London Twitter @Azeem_Majeed
  • 2.
    Declarations I have receivedfunding for research using data from NHS medical records from the NIHR, NHS, MRC and Wellcome Trust I have been using NHS data for research and planning for over 25 years I have written reports on the secondary uses of primary care data for the Department of Health in 2002 and the Association of Public Health Observatories in 2005 I worked as a Medical Adviser at the UK Office for National Statistics during the period 1997-2004 I continue to work in NHS General Practice and in NHS Public Health in addition to my academic role
  • 3.
    England’s NHS facesmajor challenges • Population of the UK is ageing • Greater support is needed for frail, older patients • Prevalence of many long term conditions – such as type 2 diabetes – is increasing • Greater focus in prevention and healthy living needed • Quality of care can vary between different general practices and geographical areas • Considerable financial pressures on government spending • Since early 2020, we have been in the midst of the global Covid-19 pandemic • Good data on the health and healthcare use of the population of England is essential for NHS planning, public health surveillance and research
  • 4.
    Expected rise inLTCs in England 2010-2040
  • 5.
    Primary medical caredata Over the last 30 years, we have seen a shift away from recording medical data on paper records in general practice Data now recorded using electronic medical records in all NHS general practices Collected through day to day clinical work of family practitioners, primary care physicians, nurses and other professionals Additional data sent electronically to practices (e.g. lab results) or added to medical records by primary care staff (hospital activity data) Provides a unique resource for NHS planning, public health surveillance and research Value of NHS data was shown in the Covid-19 pandemic
  • 6.
    Page 6 Strengths ofprimary care data Population based Most contacts with health services take place in primary care Information on most aspects of care (morbidity, physical measurements, investigations, treatment, prescribing, and outcomes & utilisation)
  • 7.
    Page 7 Weaknesses ofprimary care data Data has often come from volunteer practices & hence may not be representative (e.g. Clinical Practice Research Datalink) Quality & completeness of data recording varies widely Lack of socio-economic & ethnic data Multiple clinical systems, not currently well-linked to hospital systems Data has been difficult & expensive to access in the past GPDPR can help address some of these weaknesses
  • 8.
    Information contained inGP medical records Demographic data: e.g. date of birth, ethnicity Clinical diagnoses: e.g. diabetes, pneumonia Coded using Read codes / SNOMED in the UK Measurement data: Blood pressure, height, weight, BMI Preventive care: screening, smoking status, immunisations, health checks Prescribing data: for drugs issued by GPs Laboratory data: e.g. lipids, glucose, renal function for tests organised by GPs Covid-19 testing and vaccination data Page 8
  • 9.
    Page 9 Value ofdata can be improved through linkage Hospital Episode Statistics Office for National Statistics Mortality Records Cancer Registration Data National Audits (e.g. Diabetes) Laboratory Data (e.g. tests organised by hospital specialists) Imaging Data (e.g. x-rays, scans)
  • 10.
    Page 10 Why isprimary care data needed? Help clinicians provide medical care Plan health services Measure clinical performance Measure health service utilisation Public health surveillance Monitor inequalities Health services research, clinical epidemiology, & clinical trials
  • 11.
  • 12.
    Emergency hospital admissionsin people with Type 2 Diabetes
  • 13.
    Concerns about GPDPR Theprogramme was not well-publicised Opt-out was made difficult (paper-based, not electronic) Public concerns about how the data may be used and over confidentiality If people opt out of the programme, that could reduce the validity of the any analysis using the data Many GPs are receiving opt out requests from patients GPs have also been informed they need to perform a data protection impact assessment (DPIA)
  • 14.
    Final thoughts GPDPR isessential for the NHS in England Also essential for public health bodies, universities Important to consider how the data could also support the UK life sciences industry with suitable protections Essential there is public trust in the programme and in data confidentiality Needs to be overseen by an independent committee to build public confidence and trust Without good population-based data, the NHS “will be flying blind”